Citation Impact
Citing Papers
Identification of novel antimicrobials using a live-animal infection model
2006
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Structure-Guided Recombination Creates an Artificial Family of Cytochromes P450
2006 StandoutNobel
Understanding biofilm resistance to antibacterial agents
2003 Standout
Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands
2006
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation
1999 StandoutNatureNobel
Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries
2009
DECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
2003
Preparation of human metabolites of propranolol using laboratory‐evolved bacterial cytochromes P450
2005 StandoutNobel
Global risk of pharmaceutical contamination from highly populated developing countries
2013
Laboratory evolution of cytochrome P450 BM‐3 monooxygenase for organic cosolvents
2003 StandoutNobel
Effects of Short-Term in Vivo Exposure to Polybrominated Diphenyl Ethers on Thyroid Hormones and Hepatic Enzyme Activities in Weanling Rats
2001
The oxidative inactivation of cytochrome P450 in monooxygenase reactions
1994
Swedish Dioxin Survey: Evaluation of the H‐4‐II E Bioassay for Screening Environmental Samples for Dioxin‐Like Enzyme Induction
1991
Effects of Perinatal Exposure to a Polybrominated Diphenyl Ether (PBDE 99) on Mouse Neurobehavioural Development
2002
A NONVIRAL VECTOR SYSTEM FOR EFFICIENT GENE TRANSFER TO CORNEAL ENDOTHELIAL CELLS VIA MEMBRANE INTEGRINS1
1997
Development of a rational scale to assess the harm of drugs of potential misuse
2007 Standout
The oxidation of naphthalene and pyrene by cytochrome P450cam
1998
Toxicity of cationic lipids and cationic polymers in gene delivery
2006 Standout
The Science of Antibiotic Discovery
2020 Standout
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
The coming of age of de novo protein design
2016 StandoutNatureNobel
A review of the pharmaceutical exposome in aquatic fauna
2018
Biodegradation aspects of Polycyclic Aromatic Hydrocarbons (PAHs): A review
2009 Standout
Microfluidic organs-on-chips
2014 Standout
Metabolism in the toxicokinetics and fate of brominated flame retardants—a review
2003
Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance
2008
Protein engineering of Bacillus megaterium CYP102
2001
Antibiotic resistance in the environment
2021 Standout
Modulating protein activity using tethered ligands with mutually exclusive binding sites
2015
An overview of brominated flame retardants in the environment
2002 Standout
Protein engineering of cytochrome P450cam (CYP101) for the oxidation of polycyclic aromatic hydrocarbons
2000
Developmental exposure to low-dose PBDE-99: Tissue distribution and thyroid hormone levels
2007
Metabolomics-on-a-Chip of Hepatotoxicity Induced by Anticancer Drug Flutamide and Its Active Metabolite Hydroxyflutamide Using HepG2/C3a Microfluidic Biochips
2012
Predicted critical environmental concentrations for 500 pharmaceuticals
2010
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.
2001 Standout
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Comparison of acute lethal toxicity of commonly abused psychoactive substances
2004
Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice
1994
Neurobehavioural effects of developmental toxicity
2014 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Developmental Exposure to Brominated Diphenyl Ethers Results in Thyroid Hormone Disruption
2002
Up-regulation of Apoptosis Inhibitory Protein IAP-2 by Hypoxia
2001 StandoutNobel
Engineered Alkane‐Hydroxylating Cytochrome P450BM3 Exhibiting Nativelike Catalytic Properties
2007 StandoutNobel
Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3
2005 StandoutNobel
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Antioxidant Activity of Various Tea Extracts in Relation to Their Antimutagenicity
1995 Standout
DNA Damage in Mammalian Cells
1981 StandoutNobel
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Classes of hepatic microsomal mixed function oxidase inducers
1979
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Fundamentals of cancer metabolism
2016 Standout
Water Analysis: Emerging Contaminants and Current Issues
2014 Standout
Dietary Uptake and Biological Effects of Decabromodiphenyl Ether in Rainbow Trout (Oncorhynchus mykiss)
1999
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
2014
Metabolism of 2,2',4,4'-tetrabromodiphenyl ether in rat and mouse.
1998
Microbial metabolism of polycyclic aromatic hydrocarbons: isolation and characterization of a pyrene-degrading bacterium
1988
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Polybrominated diphenyl ethers (PBDE) in biological samples from the Swedish environment
1993
Repression of gene expression by oxidative stress
1999
Revised methods for the Salmonella mutagenicity test
1983 Standout
Polybrominated Dibenzo-p-dioxins, Dibenzofurans, and Diphenyl Ethers in Japanese Human Adipose Tissue
2003
Sampling and energy evaluation challenges in ligand binding protein design
2017 StandoutNobel
Brominated Organic Micropollutants—Igniting the Flame Retardant Issue
2004
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds.
2001
An Improved and Regiospecific Synthesis of trans-3,4-Dihydrodiol Metabolite of Benzo[b]naphtho[2,1-d]thiophene
2000
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials
2001
The ever-expanding limits of enzyme catalysis and biodegradation: polyaromatic, polychlorinated, polyfluorinated, and polymeric compounds
2020
Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their use
1976 StandoutNature
Origins and Evolution of Antibiotic Resistance
2010 Standout
Contamination of surface, ground, and drinking water from pharmaceutical production
2009
Per- and polyfluoroalkyl substances in the environment
2022 StandoutScience
Bioluminescent Antibodies for Point‐of‐Care Diagnostics
2017
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Neurotoxicity of Brominated Flame Retardants: (In)direct Effects of Parent and Hydroxylated Polybrominated Diphenyl Ethers on the (Developing) Nervous System
2011
Alkene epoxidation catalyzed by cytochrome P450 BM-3 139-3
2003 StandoutNobel
Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test
1975 Standout
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
Brominated flame retardants: cause for concern?
2003 Standout
2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity
1982 Standout
Polybrominated diphenyl ethers: occurrence, dietary exposure, and toxicology.
2001
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of A. Schmoldt being referenced
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
2003
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics
2012
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users
2003
Rat liver microsomal ring- and S-oxidation of thiaarenes with central or peripheral thiophene rings
1991
Induction of rat liver microsomal cytochrome P-450 by the pentabromo diphenyl ether Bromkal 70 and half-lives of its components in the adipose tissue
1990
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective
2006
The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment
1988
Histological and ultrastructural findings in chloroquine-induced cardiomyopathy
1995
Therapeutic and toxic blood concentrations of more than 500 drugs.
1997
Influence of monooxygenase inducers on the metabolic profile of phenanthrene in rat liver microsomes
1982
Induction of rat liver enzymes by polychlorinated biphenyls (PCBs) in dependence on the dose and chlorine content
1974
The predominant role of S-oxidation in rat liver metabolism of thiaarenes
1986
Studies on the Mechanism of Stimulation of Microsomal H2O2 Formation and Benzo(a)pyrene Hydroxylaton by Substrates and Flavone
1982
The metabolism of pyrene by rat liver microsomes and the influence of various mono-oxygenase inducers
1982